BlackRock, Inc. 13D and 13G filings for Global Blood Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Global Blood Therapeutics, Inc. GBT | BlackRock Inc. BLK | 5,353,056 8.300% | 1,669,796 (+45.33%) | Filing |
| 2021-01-29 09:56 am Sale | 2020-12-31 | 13G | Global Blood Therapeutics, Inc. GBT | BlackRock Inc. BLK | 3,683,260 6.000% | -1,171,913 (-24.14%) | Filing |